• Chloramphenicol and the New Logic of Plasmid AMR

  2026-09-12

  Chloramphenicol is more than a selection antibiotic: its mechanism and workflow utility offer translational researchers a disciplined way to study plasmid maintenance, resistance-gene localization, and horizontal transfer. This article connects molecular biology practice with recent carbapenem-resistant Enterobacter cloacae findings while defining the limits of that cross-domain interpretation.

• TRAP-1 Reactivates p53Y220C Through Induced Proximity

  2026-09-11

  The bioRxiv preprint reports TRAP-1, a small-molecule chemical inducer of proximity that brings mutant p53Y220C into a ternary complex with BRD4. This interaction rapidly increases p21 and other p53 target genes and suppresses growth in p53Y220C-expressing pancreatic cancer cell lines, providing evidence that transcriptional reactivation can be achieved without relying solely on mutant-protein stabilization.

• Angiotensin 1/2 (5-7): RAS Research Guide

  2026-09-11

  Angiotensin 1/2 (5-7) is the H2N-Ile-His-Pro-OH peptide, a short angiotensin fragment supplied for renin-angiotensin system research. Product specifications support controlled biochemical workflows, while a 2025 study provides in vitro evidence that this fragment can enhance SARS-CoV-2 spike–AXL binding.

• Molnupiravir Protects Mice from Bourbon Virus Disease

  2026-09-10

  The reference study demonstrates that molnupiravir can inhibit Bourbon virus replication in cell culture and reduce lethal disease, thrombocytopenia, tissue viral burden, and liver and spleen pathology in mice. Its most important translational insight is that benefit was observed not only with pre-exposure administration but also when treatment began 24 or 48 hours after infection, supporting further evaluation of an orally available antiviral strategy for Bourbon virus.

• Triptolide (PG490) Workflow for Cancer Research

  2026-09-10

  Build reproducible Triptolide workflows around nanomolar transcriptional suppression, invasion assays, immune-cell apoptosis, and cell-cycle-aware imaging. This guide connects PG490’s established RNAPII, IL-2, NF-κB, and matrix-remodeling effects with a new experimental framework for studying transcription condensates and genome stability.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide

  2026-09-09

  Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides fluorescent detection of goat IgG used as a primary or assay-linked immunoglobulin in ICC/IF, IHC, flow cytometry, and ELISA workflows. It should not be used for direct antigen detection or with non-goat primary antibodies unless cross-reactivity has been specifically validated.

• Trichostatin A: HDAC Workflows and Optimization

  2026-09-09

  Trichostatin A (TSA) gives researchers a reversible way to probe HDAC-dependent chromatin, differentiation, cell-cycle, and cytoskeletal biology. This practical guide connects cancer assays with a recent HDAC6–tubulin lactylation discovery while emphasizing controls, exposure design, and troubleshooting.

• Nifedipine (BAY-a-1040) Assay Workflows

  2026-09-08

  Nifedipine (BAY-a-1040) provides a controlled way to test how L-type calcium influx shapes cell signaling, contraction, viability, and transport. Its greatest experimental value emerges when calcium perturbation is paired with orthogonal PXR and CYP measurements rather than interpreted as a direct liver-metabolism signal.

• MLN8237: A Mechanistic Mitosis Assay Guide

  2026-09-08

  MLN8237 (Alisertib) is more than a selective Aurora A inhibitor: it can serve as a mechanistic probe for connecting mitotic disruption, aneuploidy, and apoptosis. This guide integrates product pharmacology with a flow-cytometric assay framework to improve experimental design and interpretation.

• NSC 87877: A Practical Shp2 Inhibitor Guide

  2026-09-07

  This scenario-based guide explains how NSC 87877, SKU A4544, can be used to design more interpretable Shp2 signaling, cell viability, proliferation, and cytotoxicity experiments. It covers assay compatibility, concentration selection, formulation controls, evidence translation, and practical product-selection criteria.

• TRAP-1 Reactivates Mutant p53Y220C

  2026-09-07

  The preprint reports TRAP-1, a chemical inducer of proximity that assembles mutant p53Y220C and BRD4 into a ternary complex, restoring transcriptional activity rather than merely stabilizing the mutant protein. In p53Y220C-expressing pancreatic cancer cell lines, this mechanism rapidly increased p21 and other p53 target genes while inhibiting cell growth, although broader validation remains necessary.

• Self-Assembling EVMPs for Extrahepatic mRNA Delivery

  2026-09-05

  This ACS Nano study introduces a bottom-up enveloped virus-mimicking particle (EVMP) assembled from a designed peptide, mRNA, and tissue-selective phospholipids. The platform enabled substantial delivery to lung and spleen, including endothelial and immune cells, while supporting repeated dosing and IL-12 mRNA treatment in a metastatic lung tumor model.

• Polybrene and the Translational Logic of p53 Reactivation

  2026-09-04

  A translational strategy for using Polybrene as a controlled gene-delivery variable when studying mutant p53 biology, including TRAP-1–mediated reactivation of p53Y220C. The article connects charge-mediated viral uptake with assay rigor, reproducibility, and the limits of extrapolating delivery performance into oncology conclusions.

• Cellular Senescence Signatures in Abdominal Aortic Aneurysm

  2026-09-04

  The reference study integrates transcriptomic analysis, cellular senescence gene sets, machine learning, and experimental validation to identify ETS1 and ITPR3 as candidate biomarkers for abdominal aortic aneurysm. Its workflow offers a practical framework for moving from discovery datasets to stage-aware validation while highlighting senescent endothelial cells as a potentially important component of aneurysm biology.

• Computational Hapten Design for Dual-Toxin Biosensing

  2026-09-03

  This 2026 study combines molecular similarity analysis, quantum chemical calculations, and antibody engineering to create a dual-target fluorescent immunochromatographic assay for amatoxins and phallotoxins in mushrooms. Its main contribution is the use of computationally guided hapten selection to improve uniform antibody recognition across chemically related toxins, enabling sensitive simultaneous screening in fresh and dried mushroom samples.

8011 records 1/535 page Next 12345 下5页 Last page